TY - JOUR
T1 - Proposed indications for limited resection of early ampulla of Vater carcinoma
T2 - Clinico-histopathological criteria to confirm cure
AU - Aiura, Koichi
AU - Hibi, Taizo
AU - Fujisaki, Hiroto
AU - Kitago, Minoru
AU - Tanabe, Minoru
AU - Kawachi, Shigeyuki
AU - Itano, Osamu
AU - Shinoda, Masahiro
AU - Yagi, Hiroshi
AU - Masugi, Yohei
AU - Sakamoto, Michiie
AU - Kitagawa, Yuko
PY - 2012/11
Y1 - 2012/11
N2 - Background Limited resection is reserved for patients with high operative risk or benign adenomas. We aimed to define indications for limited resection of early ampulla of Vater carcinoma with curative intent through detailed preoperative examinations and histopathological evaluations. Methods We performed a retrospective cohort study of all consecutive Japanese patients who underwent resection for ampulla of Vater neoplasms at our hospital from 1986 to 2010. Results A total of 75 patients were identified. Moderately/ poorly differentiated histology, lympho-vascular/ perineural invasion, and duodenal/pancreatic invasion were significant risk factors for lymph node metastases. Macroscopically, non-exposed protruded- or ulcerative-type disease did not correlate directly with lymph node metastases; however, these tumor types were associated with other invasive features. In a subset of early carcinomas fulfilling the conditions of exposed protruded adenoma or papillary/well-differentiated adenocarcinoma determined by endoscopic biopsy, negative duodenal invasion determined by endoscopic ultrasonography, no tumor infiltration into the pancreatic duct determined by intraductal ultrasound, and diameter of the pancreatic duct ≤3 mm determined by endoscopic retrograde cholangiopancreatography (N = 11), the incidence of lymph node metastasis and tumor infiltration into the pancreatic duct was 0%. Conclusion Strictly selected patients with early ampulla of Vater carcinomas may benefit from limited resection if the resected specimen is evaluated to confirm all histopathological criteria.
AB - Background Limited resection is reserved for patients with high operative risk or benign adenomas. We aimed to define indications for limited resection of early ampulla of Vater carcinoma with curative intent through detailed preoperative examinations and histopathological evaluations. Methods We performed a retrospective cohort study of all consecutive Japanese patients who underwent resection for ampulla of Vater neoplasms at our hospital from 1986 to 2010. Results A total of 75 patients were identified. Moderately/ poorly differentiated histology, lympho-vascular/ perineural invasion, and duodenal/pancreatic invasion were significant risk factors for lymph node metastases. Macroscopically, non-exposed protruded- or ulcerative-type disease did not correlate directly with lymph node metastases; however, these tumor types were associated with other invasive features. In a subset of early carcinomas fulfilling the conditions of exposed protruded adenoma or papillary/well-differentiated adenocarcinoma determined by endoscopic biopsy, negative duodenal invasion determined by endoscopic ultrasonography, no tumor infiltration into the pancreatic duct determined by intraductal ultrasound, and diameter of the pancreatic duct ≤3 mm determined by endoscopic retrograde cholangiopancreatography (N = 11), the incidence of lymph node metastasis and tumor infiltration into the pancreatic duct was 0%. Conclusion Strictly selected patients with early ampulla of Vater carcinomas may benefit from limited resection if the resected specimen is evaluated to confirm all histopathological criteria.
KW - Ampulla of Vater carcinoma
KW - Criteria
KW - Indication
KW - Limited resection
KW - Local resection
UR - http://www.scopus.com/inward/record.url?scp=84872201161&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872201161&partnerID=8YFLogxK
U2 - 10.1007/s00534-011-0492-4
DO - 10.1007/s00534-011-0492-4
M3 - Article
C2 - 22203456
AN - SCOPUS:84872201161
SN - 1868-6974
VL - 19
SP - 707
EP - 716
JO - Journal of Hepato-Biliary-Pancreatic Sciences
JF - Journal of Hepato-Biliary-Pancreatic Sciences
IS - 6
ER -